Real-world Outcomes with Tisagenlecleucel in Aggressive B-cell Lymphoma: Subgroup Analyses from the CIBMTR Registry
Journal for immunotherapy of cancer(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined